This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Michael S Bennett: Innovator in Human Cell Engineering
Introduction
Michael S Bennett is a prominent inventor based in Tucson, AZ (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered human cells. His work focuses on creating innovative solutions for viral infections, showcasing his dedication to advancing medical science.
Latest Patents
Michael S Bennett holds a patent for "Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells." This patent discloses recombinant human progenitor cells that are created by transducing a human hematopoietic stem cell with a vector containing a nucleic acid molecule. This molecule encodes a human T cell receptor that is specific to viruses, such as Human Immunodeficiency Virus, or an epitope thereof. The recombinant human progenitor cells are designed to differentiate and mature into engineered human thymocytes and engineered human T cells. The patent also outlines methods for inhibiting, reducing, or treating viral infections in subjects, including humans, by administering these engineered cells.
Career Highlights
Michael S Bennett is affiliated with the University of California, where he continues to engage in groundbreaking research. His work has led to advancements in the understanding and treatment of viral infections, making a significant impact in the field of immunology.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Scott G Kitchen and Otto O Yang. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Michael S Bennett is a key figure in the field of human cell engineering, with a focus on developing innovative therapies for viral infections. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.
